Impact of Introducing the Pletaal Assist System on Drug Adherence in Outpatients with Ischaemic Stroke: A Pilot Study

References

• McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother. 2002;36(9):1331–1336. doi:10.1345/aph.1A333
   PubMed Web of Science ®Google Scholar
• Schiff GD, Fung S, Speroff T, McNutt RA. Decompensated heart failure: symptoms, patterns of onset, and contributing factors. Am J Med. 2003;114(8):625–630. doi:10.1016/S0002-9343(03)00132-3
   Web of Science ®Google Scholar
• Senst BL, Achusim LE, Genest RP, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health-Syst Pharm. 2001;58(12):1126–1132. doi:10.1093/ajhp/58.12.1126
   PubMed Web of Science ®Google Scholar
• Misdrahi D, Llorca PM, Lançon C, Bayle FJ.L’observance dans la schizophrénie: facteurs prédictifs, voies de recherches, implications thérapeutiques [Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications]. Encephale. 2002;28(3 Pt 1):266–272.
   Google Scholar
• Rodgers PT, Ruffin DM. Medication nonadherence: part II – a pilot study in patients with congestive heart failure. Manag Care Interface. 1998;11(9):67–69,75.
   PubMedGoogle Scholar
• Sandercock PAG, Counsell C, Tseng MC, Cecconi E. Oral antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2014;(3):CD000029.
   Web of Science ®Google Scholar
• Maulaz AB, Bezerra DC, Michel P, Bogousslavsky J. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol. 2005;62(8):1217–1220. doi:10.1001/archneur.62.8.1217
   PubMedGoogle Scholar
• Glader EL, Sjolander M, Eriksson M, Lundberg M. Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke. Stroke. 2010;41(2):397–401. doi:10.1161/STROKEAHA.109.566950
   PubMed Web of Science ®Google Scholar
• Bushnell CD, Zimmer LO, Pan W, et al. Persistence with stroke prevention medications 3 months after hospitalization. Arch Neurol. 2010;67(12):1456–1463. doi:10.1001/archneurol.2010.190
   PubMedGoogle Scholar
• Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013;34(38):2940–2948. doi:10.1093/eurheartj/eht295
   PubMed Web of Science ®Google Scholar
• Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002;16(2):269–277. doi:10.1097/00002030-200201250-00017
   PubMed Web of Science ®Google Scholar
• Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance? Hypertension. 1980;2(6):757–764. doi:10.1161/01.HYP.2.6.757
   PubMed Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497. doi:10.1056/NEJMra050100
   PubMed Web of Science ®Google Scholar
• Checchi KD, Huybrechts KF, Avorn J, Kesselheim AS. Electronic medication packaging devices and medication adherence: a systematic review. JAMA. 2014;312(12):1237–1247. doi:10.1001/jama.2014.10059
   PubMed Web of Science ®Google Scholar
• Kimura Y, Tani T, Kanbe T, Watanabe K. Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneimittelforschung. 1985;35(7A):1144–1149.
   Web of Science ®Google Scholar
• Yasunaga K, Mase K. Antiaggregatory effect of oral cilostazol and recovery of platelet aggregability in patients with cerebrovascular disease. Arzneimittelforschung. 1985;35(7A):1189–1192.
   Web of Science ®Google Scholar
• Shinohara Y, Katayama Y, Uchiyama S, et al. Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial. Lancet Neurol. 2010;9(10):959–968. doi:10.1016/S1474-4422(10)70198-8
   PubMed Web of Science ®Google Scholar
• Rudd P, Byyny RL, Zachary V, et al. Pill count measures of compliance in a drug trial: variability and suitability. Am J Hypertens. 1988;1(3 Pt 1):309–312. doi:10.1093/ajh/1.3.309
   PubMed Web of Science ®Google Scholar
• Pullar T, Kumar S, Tindall H, Feely M. Time to stop counting the tablets? Clin Pharmacol Ther. 1989;46(2):163–168. doi:10.1038/clpt.1989.121
   PubMed Web of Science ®Google Scholar
• Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989;261(22):3273–3277. doi:10.1001/jama.1989.03420220087032
   PubMed Web of Science ®Google Scholar
• Svarstad BL, Chewning BA, Sleath BL, Claesson C. The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37(2):113–124. doi:10.1016/S0738-3991(98)00107-4
   PubMed Web of Science ®Google Scholar
• Alili M, Vrijens B, Demonceau J, Evers SM, Hiligsmann M. A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence. Br J Clin Pharmacol. 2016;82(1):268–279. doi:10.1111/bcp.12942
   Web of Science ®Google Scholar
• Diaz E, Levine HB, Sullivan MC, et al. Use of the medication event monitoring system to estimate medication compliance in patients with schizophrenia. J Psychiatry Neurosci. 2001;26(4):325–329.
   PubMed Web of Science ®Google Scholar
• Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150(9):1881–1884. doi:10.1001/archinte.1990.00390200073014
   PubMed Web of Science ®Google Scholar
• Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296–1310. doi:10.1016/S0149-2918(01)80109-0
   PubMed Web of Science ®Google Scholar
• Han E, Sohn HS, Lee J-Y, Jang S. Health behaviors and medication adherence in elderly patients. Am J Health Promot. 2017;31(4):278–286. doi:10.4278/ajhp.150205-QUAN-709
   PubMed Web of Science ®Google Scholar
• Crowley MJ, Zullig LL, Shah BR, et al. Medication non-adherence after myocardial infarction: an exploration of modifying factors. J Gen Intern Med. 2015;30(1):83–90. doi:10.1007/s11606-014-3072-x
   PubMed Web of Science ®Google Scholar
• Juarez DT, Williams AE, Chen C, et al. Factors affecting medication adherence trajectories for patients with heart failure. Am J Manag Care. 2015;21(3):e197–e205.
   Web of Science ®Google Scholar
• Pan B, Jin X, Jun L, Qiu S, Zheng Q, Pan M. The relationship between smoking and stroke: a meta–analysis. Medicine (Baltimore). 2019;98(12):e14872. doi:10.1097/MD.0000000000014872
   PubMed Web of Science ®Google Scholar